Thromboxane A2 and Knee Osteoarthritis Study
Treatments studied
Part of Bones, joints & muscles clinical trials.
This trial is studying a substance called thromboxane A2 in people with knee osteoarthritis and joint swelling. It aims to help doctors better understand this condition and find new ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have knee osteoarthritis with swelling or fluid in the joint.
- You must not have an inflammatory disease like rheumatoid arthritis or lupus.
- You must not be taking blood-thinning medication (anticoagulants).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies knee tissue to find better ways to diagnose early osteoarthritis. It may help people who need a knee injection for pain relief.
This study examines joint tissue from people with different types of arthritis to understand the disease better. It may help researchers develop better treatments in the future.
This study tests the safety of an experimental injection called OA-SYS for people with moderate to severe knee osteoarthritis. It may help if you have not had recent injections or certain other health problems.
This trial tests a new treatment called embolization using a special material (NBGM200) to block certain blood vessels in the knee. It may help reduce pain and improve function in people with knee osteoarthritis.
This trial tests whether taking tranexamic acid (a medicine that helps blood clot) for several days after knee replacement surgery reduces bleeding and improves recovery. It may help patients who have a standard knee replacement and are not on blood thinners.
This trial tests whether taking a longer course of a medication called TXA after joint replacement surgery can help prevent bleeding. TXA is a medicine that helps blood clot, and the goal is to see if taking it for more days reduces the need for blood transfusions.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.